Back to search
Chronic Myeloid Leukemia, BCR-ABL1 Positive
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Myeloid Leukemia, BCR-ABL1 Positive trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Chronic Myeloid Leukemia, BCR-ABL1 Positive trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The aim of this study is to assess the real-world effectiveness of asciminib in Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+…
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for leukemia compared to individuals who do no…
This phase II trial studies how well a donor stem cell transplant, treosulfan, fludarabine, and total-body irradiation work in treating patients with blood canc…
This phase II trial studies how well dexrazoxane hydrochloride works in preventing heart-related side effects of chemotherapy in participants with blood cancers…
This phase II clinical trial studies how well personalized natural killer (NK) cell therapy works after chemotherapy and umbilical cord blood transplant in trea…
This phase II trial studies how well blinatumomab, methotrexate, cytarabine, and ponatinib work in treating patients with Philadelphia chromosome (Ph)-positive,…
This phase II trial studies how well pembrolizumab and dasatinib, imatinib mesylate, or nilotinib work in treating patients with chronic myeloid leukemia and pe…
This phase I/II trial studies how well cytokine-treated veto cells work in treating patients with hematologic malignancies following stem cell transplant. Givin…